Financing Entrepreneurial Excellence

Juventas Therapeutics

Juventas Therapeutics

Early Stage Partners participated in the Series A investment in the life sciences company Juventas Therapeutics, which is developing Stromal Derived Factor, or SDF-1, to repair damage to heart and other tissue. SDF-1 is a universal recruiter of a body's own stem cells to areas of damaged tissue.

Find Out More About ESP

Staff Photo

Mike Bunker sits on the board of Juventas Therapeutics.

Early Stage Partners | 1801 East 9th Street, Suite 1700 | Cleveland, Ohio 44114 | Phone: 216.781.4600
Designed & Developed by: MindStreams